Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NONOF NOVO NORDISK A/S > Detailed Quotes

NONOF NOVO NORDISK A/S

98.600
-3.590-3.51%
Close 09/30 16:00 ET
High
103.400
Open
101.190
Turnover
716.93K
Low
97.400
Pre Close
102.190
Volume
7.15K
Market Cap
222.75B
P/E(TTM)
31.65
52wk High
123.700
Shares
2.26B
P/E(Static)
31.09
52wk Low
90.580
Float Cap
158.81B
Bid/Ask %
0.00%
Historical High
123.700
Shs Float
1.61B
Volume Ratio
0.22
Historical Low
70.400
Dividend TTM
1.465
Div Yield TTM
1.43
P/B
22.93
Dividend LFY
1.49%
Div Yield LFY
1.45%
Turnover Ratio
0.00%
Amplitude
5.87%
Avg Price
100.340
Lot Size
1
Float Cap
158.81B
Bid/Ask %
0.00%
Historical High
123.700
Shs Float
1.61B
Volume Ratio
0.22
Historical Low
70.400
Dividend TTM
1.465
P/B
22.93
Dividend LFY
1.49%
Turnover Ratio
0.00%
Amplitude
5.87%
Avg Price
100.340
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsv?rd, Denmark.
CEO: Mr. Lars Fruergaard Jorgensen
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...